Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 30 Parkinson's papers of 1,346 | 0.55 |
| pathways Reactome | 3 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 9817
Sealed predictions
- CTH in dopamine neurons, braak+0.27 (p 0.489) → +0.48 (p 0.193)receipt 9823
Swarm cases
receipt 9823: CTH in dopamine neurons, braak
- power
- full sample +0.41 (p 0.095, n 18), 95% CI -0.08 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.40 (p 0.101, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.32 (p 0.191, n 18). could be the mix.
- skeptic
- leave-one-out range +0.33 to +0.51, sign flips 0; without severely affected donors +0.41 (p 0.095, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CTH in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts